Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model o f nonalcoholic steatohepatitis

Hu, YB; Liu, XY; Zhan, W

Hu, YB (reprint author), Wuhan Fourth Hosp, Dept Gastroenterol, 473 Hanzheng St, Wuhan 430033, Hubei, Peoples R China.

DRUG DESIGN DEVELOPMENT AND THERAPY, 2018; 12 (): 2213

Abstract

Introduction: Nonalcoholic steatohepatitis (NASH) is largely driven by the dysregulation of liver metabolism and inflammation. Bile acids and their re......

Full Text Link